Progress in oncolytic virotherapy for the treatment of thyroid malignant neoplasm

Apoptotic induction of lung adenocarcinoma A549 cells infected by recombinant RVG Newcastle disease virus (rL-RVG) in vitro

Strong T‑cell costimulation can reactivate tumor antigen‑specific T cells in late‑stage metastasized colorectal carcinoma patients: results from a phase Ⅰ clinical study

Long-term remission of prostate cancer with extensive bone metastases upon immuno- and virotherapy: A case report

Intravenously injected Newcastle disease virus in non-human primates is safe to use for oncolytic virotherapy

Effect of recombinant Newcastle disease virus transfection on lung adenocarcinoma A549 cells

Newcastle disease virotherapy induces long-term survival and tumor-specific immune memory in orthotopic glioma through the induction of immunogenic cell death

Immunomodulatory effects of Newcastle disease virus AF2240 strain on human peripheral blood mononuclear cells

Multimodal cancer therapy involving oncolytic newcastle disease virus, autologous immune cells, and bi-specific antibodies

Newcastle disease virus interaction in targeted therapy against proliferation and invasion pathways of glioblastoma multiforme